| Cell line name |
LIM1215 KRAS (G12C/+) |
|---|
| Synonyms |
KRAS (G12C/+) LIM1215 |
|---|
| Accession |
CVCL_LC81 |
|---|
| Resource Identification Initiative |
To cite this cell line use: LIM1215 KRAS (G12C/+) (RRID:CVCL_LC81) |
|---|
| Comments |
Population: Caucasian.
Characteristics: Heterozygous knockin of a KRAS activating mutation.
Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688. |
|---|
| Sequence variations |
- Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-007).
- Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
|
|---|
| Disease |
Colon adenocarcinoma (NCIt: C4349)
Lynch syndrome (NCIt: C8494)
Lynch syndrome (ORDO: Orphanet_144) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_2574 (LIM1215) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
34Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=22722830; DOI=10.1038/nature11156; PMCID=PMC3927413
Sandra Misale, Rona D. Yaeger, Sebastijan Hobor, Elisa Scala, Manickam Janakiraman, David Liska, Emanuele Valtorta, Roberta Schiavo, Michela Buscarino, Giulia Siravegna, Katia Bruna Bencardino ...Show all 26 authors... , Andrea Cercek, Chin-Tung Chen, Silvio Veronese, Carlo Zanon, Andrea Sartore-Bianchi, Marcello Gambacorta, Margherita Gallicchio, Efsevia Vakiani, Valentina Boscaro, Enzo Medico, Martin R. Weiser, Salvatore Siena, Federica Di Nicolantonio, David B. Solit, Alberto Bardelli; Show fewer authors
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.
Nature 486:532-536(2012) |
|---|
| Cross-references |
|---|
| Cell line collections (Providers) |
Horizon_Discovery; HD+116-007
|
|---|
| Cell line databases/resources |
cancercelllines; CVCL_LC81
|
|---|
| Encyclopedic resources |
Wikidata; Q54902519
|
|---|
| Entry history |
|---|
| Entry creation | 22-Aug-2017 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 15 |
|---|
